BioCryst Announces Approval of ORLADEYO® (berotralstat) by Swissmedic
RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
Month: June 2022
Albireo to Present New Data at the 54th Annual Meeting of ESPGHAN
– Four abstracts accepted of Phase 3 data from PEDFIC 1 and PEDFIC 2 trials…
Longboard Pharmaceuticals to Present at the JMP Securities 2022 Life Sciences Conference on June 15
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) — Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage…
Palisade Bio to Present at the 2022 BIO International Convention
In-person presentation on Monday, June 13th at 1:45 PM PT CARLSBAD, Calif., June 07, 2022…
Clearmind Medicine Announces Positive Pre-Clinical Results for Cocaine Addiction Treatment
The dedicated treatment demonstrated a significant decrease in preference for an area associated with cocaine…
Acer Therapeutics Issues Statement Regarding PDUFA Target Action Date for ACER-001
NEWTON, Mass., June 07, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
SciSparc Ltd. Announces Initial Positive Results for the Cocaine Addiction Treatment of Clearmind Medicine Inc.
SciSparc and Clearmind recently announced the filing of a patent application related to treating cocaine…
Pharvaris Participates in the Kinin 2022 Conference
Pharvaris’ tailored drug development approach to enable treatment of people living with all types of…
Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital
COPENHAGEN, Denmark, June 07, 2022 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
Ceapro Announces Results of 2022 Shareholders’ Meeting
EDMONTON, Alberta, June 07, 2022 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”…
Eyenovia Announces Planned Chief Executive Officer Transition
CEO Dr. Sean Ianchulev will transition to non-executive Chairman of the Board NEW YORK, June…
Observed Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 Update
Potential for Amplified Therapeutic Effect of REACT™ with Bilateral Kidney Injections Potential to report data…
ORYZON Awarded EU Seal of Excellence and Public Financing of $2M USD to Develop Iadademstat in Acute Myeloid Leukemia
Non-refundable funds from the Next Generation-EU program MADRID, Spain and CAMBRIDGE, Mass., June 07, 2022…
scPharmaceuticals Inc. Announces Abstracts Accepted for Presentation at the American Association of Heart Failure Nurses 18th Annual Meeting
Oral and moderated poster presentations of FREEDOM-HF study to be presented BURLINGTON, Mass., June 07,…
Enlivex to Present at the 2022 Jefferies Healthcare Conference
Nes-Ziona, Israel, June 07, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage…
Soleno Therapeutics Announces Presentations at ENDO 2022
REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
Jasper Therapeutics to Participate in the William Blair 42nd Annual Growth Stock Conference
REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference
SAN DIEGO and REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc….
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on Hydroxyl Dendrimer-Based Therapeutics at the 2022 Neurofibromatosis (NF) Conference
Scientific collaborators at Indiana University School of Medicine will present preclinical data demonstrating Ashvattha’s hydroxyl…
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference
WARREN, N.J., June 07, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…